Endocyte (ECYT) Tops Q1 EPS by 5c

Endocyte (NASDAQ: ECYT) reported Q1 EPS of ($0.27), $0.05 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Jefferies Assumes Allied Blenders (ABDL:IN) at Buy
• Piper Sandler's Weekly Focus Idea: Principal Financial Group (PFG)